Form EFFECT Akari Therapeutics Plc
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 15, 2026 |
| Accession Number: | 0001493152-26-016154 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AIR Control Concepts Welcomes 74th Governor of Virginia Glenn Youngkin to Board of Directors
- Maxime Collins Inc. Launches Dedicated Print-Ready Verification Service for Front-of-Package Labelling Compliance
- Via Transportation, Inc. Securities Class Action Result of Undisclosed Growth Obstacles and Approximately 70% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
